| Matthew James Dellaquila, MD | |
|
18101 Oakwood Blvd, Dearborn, MI 48124-4089 | |
| (734) 263-2383 | |
| (734) 436-8626 |
| Full Name | Matthew James Dellaquila |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 18101 Oakwood Blvd, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205152725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301111350 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Allegiance Health | Jackson, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| W.a. Foote Memorial Hospital, Inc. | 0244136067 | 435 |
News Archive
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF).
Research to develop more effective treatments for triple negative breast cancer - a difficult disease to cure - could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.
The fifth anniversary of the international treaty to address the global tobacco epidemic presents a significant opportunity for President Obama to continue his strong leadership on tobacco control by submitting the treaty to the Senate for ratification and urging its quick approval.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 1 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003989690 PECOS PAC ID: 0547178311 Enrollment ID: O20031111000300 |
News Archive
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF).
Research to develop more effective treatments for triple negative breast cancer - a difficult disease to cure - could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.
The fifth anniversary of the international treaty to address the global tobacco epidemic presents a significant opportunity for President Obama to continue his strong leadership on tobacco control by submitting the treaty to the Senate for ratification and urging its quick approval.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 1 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF).
Research to develop more effective treatments for triple negative breast cancer - a difficult disease to cure - could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.
The fifth anniversary of the international treaty to address the global tobacco epidemic presents a significant opportunity for President Obama to continue his strong leadership on tobacco control by submitting the treaty to the Senate for ratification and urging its quick approval.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 1 days ago
| Entity Name | Carelink Of Jackson A Community Owned Specialty Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053781625 PECOS PAC ID: 3678484482 Enrollment ID: O20040114000467 |
News Archive
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF).
Research to develop more effective treatments for triple negative breast cancer - a difficult disease to cure - could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.
The fifth anniversary of the international treaty to address the global tobacco epidemic presents a significant opportunity for President Obama to continue his strong leadership on tobacco control by submitting the treaty to the Senate for ratification and urging its quick approval.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew James Dellaquila, MD 2006 Hogback Rd, Ste 5a, Ann Arbor, MI 48105 Ph: (734) 786-4989 | Matthew James Dellaquila, MD 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (734) 263-2383 |
News Archive
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF).
Research to develop more effective treatments for triple negative breast cancer - a difficult disease to cure - could someday benefit all breast cancer patients, reports Dr. Frederick C. Tucker, Jr. of Fredericksburg Oncology.
The fifth anniversary of the international treaty to address the global tobacco epidemic presents a significant opportunity for President Obama to continue his strong leadership on tobacco control by submitting the treaty to the Senate for ratification and urging its quick approval.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 1 days ago
Dr. Clarence C. Rayos, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 19401 Hubbard Dr, Dearborn, MI 48126 Phone: 313-982-8280 Fax: 313-982-8271 | |
Dr. Debora Ann Kaczynski, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-1573 | |
Dr. Lisa Michelle Tyra Soranno, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-982-5159 Fax: 313-982-5115 | |
Ms. Heather Assad Zacur, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 24327 Ford Rd, Dearborn, MI 48128 Phone: 617-732-8210 | |
Dr. Aaron Scott Goldfein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2040 Monroe St, Suite #209, Dearborn, MI 48124 Phone: 313-359-3800 Fax: 313-277-4100 | |
Zulfiqar Ahmed, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dept Of Anesthesiology, Dearborn, MI 48124 Phone: 313-593-7050 Fax: 313-982-5110 | |
James Lambert, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Suite 206, Dearborn, MI 48124 Phone: 313-593-1573 |